Home > 2016 RANZCO > Paediatric ophthalmology

Session : Paediatric ophthalmology

SESSION INFORMATION

Date: 21 Nov 2016

Time: 5:00 pm - 6:30 pm

Meeting: 2016 RANZCO

ABSTRACT NUMBER : 88

VISUAL ACUITY CHANGES IN CHILDREN AND ADOLESCENTS WITH INFANTILE NYSTAGMUS

ABSTRACT NUMBER : 89

REFRACTIVE ERROR IN CHILDREN WITH ALBINISM

ABSTRACT NUMBER : 90

SPONTANEOUS RETROORBITAL HAEMATOMA PRESENTING WITH UNILATERAL PROPTOSIS IN TWO NEWBORNS

ABSTRACT NUMBER : 91

RETINAL HAEMORRHAGES IN RETINOPATHY OF PREMATURITY: A PREDICTOR OF CLINICAL NEED FOR RETINAL LASER

ABSTRACT NUMBER : 92

SUBDURAL EMPYEMA AND SUPERIOR OPHTHALMIC VEIN THROMBOSIS FOLLOWING ORBITAL CELLULITIS: A CASE REPORT

ABSTRACT NUMBER : 93

“THE BUNG EYE”

MOST VIEWED ABSTRACTS

COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A ?TREAT AND EXTEND? PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12- MONTH INTERIM ANALYSIS OF THE RIVAL STUDY

CLINIC UTILITY OF POLYGENIC RISK SCORE IN EARLY GLAUCOMA: APPLICATION IN A NATIONAL PROSPECTIVE EARLY MANIFEST GLAUCOMA COHORT

A POLYGENIC RISK SCORE THAT PREDICTS FAMILIAL GENETIC RISK IN GLAUCOMA

COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A ?TREAT AND EXTEND? PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12- MONTH INTERIM ANALYSIS OF THE RIVAL STUDY

THE CLINICAL USE OF TOPICAL HYPERTONIC SALINE EYE DROPS IN A TERTIARY REFERRAL EYE CARE CENTRE IN SYDNEY, AUSTRALIA

RANDOMISED, OPEN-LABEL STUDY TO EVALUATE 2 INTRAVITREAL AFLIBERCEPT TREAT-AND-EXTEND DOSING REGIMENS IN WET AGE-RELATED MACULAR DEGENERATION: 52-WEEK OUTCOMES FROM ALTAIR

CHANGES IN AUSTRALIAN PRACTICE PATTERNS FOR GLAUCOMA MANAGEMENT

COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED FOLLOWING A ?TREAT AND EXTEND? PROTOCOL: EFFICACY VARIABLES FROM THE PRE-SPECIFIED 12- MONTH INTERIM ANALYSIS OF THE RIVAL STUDY

2. COMPARISON OF RANIBIZUMAB AND AFLIBERCEPT FOR NEOVASCULAR AGE- RELATED MACULAR DEGENERATION (NAMD) USING A TREAT-AND-EXTEND REGIMEN: RESULTS OF THE 24-MONTH SECONDARY EFFICACY OUTCOMES FROM THE RIVAL STUDY, A RANDOMIZED CLINICAL TRIAL

RECENT MEETINGS

2018 RANZCO, 50th Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists

17 November - 21 November 2018

Adelaide Convention Centre, South Australia

2017 RANZCO, 49th Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists

27 October - 1 November 2017

Perth Convention and Exhibition Centre, Perth

ARCHIVES

© COPYRIGHT 2016 The Royal Australian and New Zealand College of Ophthalmologists